clinical trials for

dogs

trial name conditions enrollment ends
A dose-finding study of cannabidiol in dogs with idiopathic epilepsy epilepsy December 31, 2024 Adjuvant immunotherapy combination with losartan/toceranib/ladarixin for non-metastatic osteosarcoma osteosarcoma Asparaginase, procarbazine, prednisone, and lomustine for canine multicentric lymphoma lymphoma Canine Brain Tumor Vaccine Clinical Trial glioma Canine traumatic injury stabilization (BodeVet/LoVLETR) penetrating trauma Clinical characteristics and long-term outcome in dogs diagnosed with a ductal plate malformation ductal plate malformation May 1, 2034 Combination trametinib and sapanisertib for canine mucosal melanoma oral melanoma COTC027: Preclinical Comparison of Two Hypomethylating Nucleosides in Tumor-Bearing Dogs solid tumor Evaluation of adaptation time in dogs undergoing limb amputation for osteosarcoma osteosarcoma Evaluation of thromboprophylaxis medications in dogs with protein-losing enteropathy protein-losing enteropathy May 1, 2024 Focal adhesion kinase inhibition to improve losartan-toceranib immunotherapy in canine metastatic osteosarcoma osteosarcoma Incidence of Subclinical Tumor Lysis Syndrome in Dogs with Multicentric Lymphoma lymphoma Investigation of the anti-inflammatory effect of cannabidiol on uveitis following cataract surgery in dogs diabetic cataracts September 1, 2023 Phase I clinical trial of NIH 972 in dogs with spontaneously occurring sarcomas sarcoma Phase-1 evaluation of vismodegib plus carboplatin in dogs with spontaneous osteosarcoma osteosarcoma Platinum supplement trial osteoarthritis July 31, 2023 Safety and Effectiveness of GEM-IB/Docetaxel in Dogs with Osteosarcoma osteosarcoma The effect of intravenous carboplatin on pain control in dogs with appendicular osteosarcoma osteosarcoma TPLO shockwave treatment trial bilateral cranial cruciate ligament disease September 1, 2023 TRAC study: Investigating the effect of trazodone, rapamycin, and cannabidiol on cognitive dysfunction in dogs cognitive dysfunction December 31, 2030